Literature DB >> 31776277

Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.

Kai-Min Lin1, Sue-Jane Lin1, Juin-Han Lin1, Pei-Yi Lin1, Pu-Lin Teng1, Hsueh-Erh Wu1, Te-Huei Yeh2, Ying-Piao Wang3, Mei-Ru Chen1, Ching-Hwa Tsai4.   

Abstract

The strongest evidence of the oncogenicity of Epstein-Barr virus (EBV) in vitro is its ability to immortalize human primary B lymphocytes into lymphoblastoid cell lines (LCLs). Yet the underlying mechanisms explaining how the virus tempers the growth program of the host cells have not been fully elucidated. The mitogen-activated protein kinases (MAPKs) are implicated in many cellular processes and are constitutively activated in LCLs. We questioned the expression and regulation of the dual-specificity phosphatases (DUSPs), the main negative regulator of MAPKs, during EBV infection and immortalization. Thirteen DUSPs, including 10 typical and 3 atypical types of DUSPs, were tested. Most of them were downregulated after EBV infection. Here, a role of viral oncogene latent membrane protein 1 (LMP1) in limiting DUSP6 and DUSP8 expression was identified. Using MAPK inhibitors, we found that LMP1 activates extracellular signal-regulated kinase (ERK) or p38 to repress the expression of DUSP6 and DUSP8, with corresponding substrate specificity. Morphologically, overexpression of DUSP6 and DUSP8 attenuates the ability of EBV-immortalized LCL cells to clump together. Mechanistically, apoptosis induced by restoring DUSP6 and DUSP8 in LCLs indicated a novel mechanism for LMP1 to provide a survival signal during EBV immortalization. Collectively, this report provides the first description of the interplay between EBV genes and DUSPs and contributes considerably to the interpretation of MAPK regulation in EBV immortalization.IMPORTANCE Infections by the ubiquitous Epstein-Barr virus (EBV) are associated with a wide spectrum of lymphomas and carcinomas. It has been well documented that activation levels of MAPKs are found in cancer cells to translate various external or intrinsic stimuli into cellular responses. Physiologically, the dual-specificity phosphates (DUSPs) exhibit great ability in regulating MAPK activities with respect to their capability of dephosphorylating MAPKs. In this study, we found that DUSPs were generally downregulated after EBV infection. EBV oncogenic latent membrane protein 1 (LMP1) suppressed DUSP6 and DUSP8 expression via MAPK pathway. In this way, LMP1-mediated MAPK activation was a continuous process. Furthermore, DUSP downregulation was found to contribute greatly to prevent apoptosis of EBV-infected cells. To sum up, this report sheds light on a novel molecular mechanism explaining how EBV maintains the unlimited proliferation status of the immortalized cells and provides a new link to understand EBV-induced B cell survival.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  EBV

Mesh:

Substances:

Year:  2020        PMID: 31776277      PMCID: PMC6997745          DOI: 10.1128/JVI.01837-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Novel expression and regulation of TIMP-1 in Epstein Barr virus-infected cells and its impact on cell survival.

Authors:  Sue-Jane Lin; Shao-Wen Wu; Ya-Ching Chou; Jiun-Han Lin; Ya-Chi Huang; Mei-Ru Chen; Nianhan Ma; Ching-Hwa Tsai
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

2.  Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.

Authors:  Ya-Ching Chou; Sue-Jane Lin; Jean Lu; Te-Huei Yeh; Chi-Long Chen; Pei-Lun Weng; Jiun-Han Lin; Ming Yao; Ching-Hwa Tsai
Journal:  Blood       Date:  2011-06-09       Impact factor: 22.113

Review 3.  MAPK signal pathways in the regulation of cell proliferation in mammalian cells.

Authors:  Wei Zhang; Hui Tu Liu
Journal:  Cell Res       Date:  2002-03       Impact factor: 25.617

4.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

5.  Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activation.

Authors:  Aleksandra Jurek; Kenichi Amagasaki; Agnieszka Gembarska; Carl-Henrik Heldin; Johan Lennartsson
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

6.  WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression.

Authors:  Debra J Morrison; Marianne K H Kim; Windy Berkofsky-Fessler; Jonathan D Licht
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

7.  EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.

Authors:  Shu-Chun Tsai; Sue-Jane Lin; Po-Wen Chen; Wen-Yi Luo; Te-Huei Yeh; Hsei-Wei Wang; Chi-Ju Chen; Ching-Hwa Tsai
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

8.  Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection.

Authors:  Ana Cáceres; Beatriz Perdiguero; Carmen E Gómez; Maria Victoria Cepeda; Carme Caelles; Carlos Oscar Sorzano; Mariano Esteban
Journal:  PLoS Pathog       Date:  2013-11-14       Impact factor: 6.823

9.  Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer.

Authors:  Muhammad Khairi Ahmad; Nur Ainina Abdollah; Nurul Husna Shafie; Narazah Mohd Yusof; Siti Razila Abdul Razak
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

Review 10.  The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).

Authors:  Andrew M Kidger; Stephen M Keyse
Journal:  Semin Cell Dev Biol       Date:  2016-01-11       Impact factor: 7.727

View more
  3 in total

1.  Targeted Degradation of the Oncogenic Phosphatase SHP2.

Authors:  Vidyasiri Vemulapalli; Katherine A Donovan; Tom C M Seegar; Julia M Rogers; Munhyung Bae; Ryan J Lumpkin; Ruili Cao; Matthew T Henke; Soumya S Ray; Eric S Fischer; Gregory D Cuny; Stephen C Blacklow
Journal:  Biochemistry       Date:  2021-08-19       Impact factor: 3.162

Review 2.  Signaling pathways of EBV-induced oncogenesis.

Authors:  Yin Luo; Yitong Liu; Chengkun Wang; Runliang Gan
Journal:  Cancer Cell Int       Date:  2021-02-06       Impact factor: 5.722

3.  25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.

Authors:  Anna K P Serquiña; Takanobu Tagawa; Daniel Oh; Guruswamy Mahesh; Joseph M Ziegelbauer
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.